Genmab’s ovarian cancer drug meets phase 3 trial goals
Genmab’s ovarian cancer drug meets phase 3 trial goals
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Genmab’s ovarian cancer drug meets phase 3 trial goals
France mounts major security operation for fresh wave of protests
Tenable stock hits 52-week high at $43.67
Finland stocks lower at close of trade; OMX Helsinki 25 down 0.40%
Trump administration to disburse $8 billion farmer aid after election
USCB Q3 2026 slides: record earnings overshadowed by revenue miss
Rexford Industrial Q3 2026 slides: $1.5B portfolio shift, leverage falls
Why is CrowdStrike stock surging today?
Market turmoil has created a remarkable opportunity in recent weeks for retirees and those seeking secure, stable income for life.
Autoliv earnings analysis: questions answered and next catalysts
Booz Allen Hamilton earnings analysis: questions answered and next catalysts
Rogers Communications earnings analysis: questions answered and next catalysts
American Express earnings analysis: questions answered and next catalysts
Asia’s LNG imports set to reach three-month high in October
Bitcoin dipped below $81,000 as stocks fell and Brent crude hit its highest level since March, leaving the 50-day moving average in focus.
Explainer-What is going on with SpaceX’s Starlink and Starshield in Ukraine?
Ukraine embassy in Washington reopens after suspicious object causes brief disruption
Satellite images show the an oil spill spreading for miles along the coastline, shutting several beaches.
Turkey stocks lower at close of trade; BIST 100 down 0.92%
Byline Q3 2026 slides: record profit, margin expansion, deposit surge
News text belongs to its source; only the headline and a short summary appear here.